Bone Alkaline Phosphatase and Urine Hydroxyproline Assay in Pre and Postmenopausal Women in the State of Sikkim and Its Correlation with Bone Mineral Density

Overview

Journal J Midlife Health

Date 2022 Mar 10

PMID 35264838

Authors

Anne Deborah Rai

Mingma L Sherpa

Amumacha Singh

S G Thejaswi

Rinchen D Bhutia

Affiliations

Soon will be listed here.

Abstract

Introduction: Osteoporosis could be viewed as a metabolic disease. The WHO guidelines for diagnosing osteoporosis reflect structural damage only and not the metabolic imbalance that leads to it. Biochemical markers of bone turnover have been shown to provide valuable information for diagnosing and monitoring metabolic bone disease. The present study analyzed bone-specific alkaline phosphatase (BALP) and urinary hydroxyproline in pre- and postmenopausal women and correlated them with changes in bone mineral density (BMD) in the state of Sikkim. The study also intended to know the ethnicity-based disease burden in Sikkim.

Materials And Methods: A hospital-based cross-sectional study was done at a tertiary hospital in Sikkim. Blood and 24-h urine samples from 50 premenopausal and 50 postmenopausal women were analyzed for total alkaline phosphatase (ALP), BALP, and Urine Hydroxyproline. BMD was measured using the quantitative ultrasound technique by Achilles densitometer.

Results: There was a statistically significant increase in serum calcium ( = 0.01), ALP ( = 0.01), and urine hydroxyproline ( = 0.03) levels in postmenopausal women as compared to premenopausal women. Although ALP was higher in postmenopausal women, BALP isoform was more elevated in premenopausal women ( = 0.001). BMD was significantly lower in postmenopausal women ( < 0.001). It was also noted that there was a significant difference in BMD between tribal and nontribal populations ( = 0.003). Total ALP and BALP as the bone formation marker and urine hydroxyproline as a bone resorption marker added statistically significant r to BMD prediction ( < 0.05).

Conclusion: In this study, BALP combined with Urine Hydroxyproline was helpful as a screening biomarker to predict osteoporosis in postmenopausal women.

Citing Articles

The Effect of Two Years of Secukinumab Treatment on Bone Metabolism in Patients with Radiographic Axial Spondyloarthritis: Results from Daily Clinical Practice.

Siderius M, Kieskamp S, Wink F, Kroese F, Arends S, Spoorenberg A Biologics. 2023; 17:161-166.

PMID: 38115870 PMC: 10728592. DOI: 10.2147/BTT.S434318.

Circulating miR-340-5p and miR-506-3p as Two Osteo-miRNAs for Predicting Osteoporosis in a Cohort of Postmenopausal Women.

Lu Z, Cao H, Hu X J Environ Public Health. 2023; 2023:7571696.

PMID: 36761245 PMC: 9904902. DOI: 10.1155/2023/7571696.

References

Zhang X, He J, Fu W, Liu Y, Zhang Z . Associations of Serum Osteocalcin and Polymorphisms of the Osteocalcin Gene with Bone Mineral Density in Postmenopausal and Elderly Chinese Women. J Nutrigenet Nutrigenomics. 2016; 9(5-6):231-242. DOI: 10.1159/000452130. View

Lumachi F, Orlando R, Fallo F, Basso S . Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type I collagen and bone mineral density in elderly men. Preliminary results. In Vivo. 2012; 26(6):1041-4. View

Shatrugna V, Kulkarni B, Kumar P, Rani K, Balakrishna N . Bone status of Indian women from a low-income group and its relationship to the nutritional status. Osteoporos Int. 2005; 16(12):1827-35. DOI: 10.1007/s00198-005-1933-1. View

Mithal A, Bansal B, Kyer C, Ebeling P . The Asia-Pacific Regional Audit-Epidemiology, Costs, and Burden of Osteoporosis in India 2013: A report of International Osteoporosis Foundation. Indian J Endocrinol Metab. 2014; 18(4):449-54. PMC: 4138897. DOI: 10.4103/2230-8210.137485. View

Christenson R . Biochemical markers of bone metabolism: an overview. Clin Biochem. 1998; 30(8):573-93. DOI: 10.1016/s0009-9120(97)00113-6. View

Kress B, Mizrahi I, Armour K, Marcus R, Emkey R, Santora 2nd A . Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women. Clin Chem. 1999; 45(7):1009-17. View

Ross P, Knowlton W . Rapid bone loss is associated with increased levels of biochemical markers. J Bone Miner Res. 1998; 13(2):297-302. DOI: 10.1359/jbmr.1998.13.2.297. View

Ingle B, Machado A, Pereda C, Eastell R . Monitoring alendronate and estradiol therapy with quantitative ultrasound and bone mineral density. J Clin Densitom. 2005; 8(3):278-86. DOI: 10.1385/jcd:8:3:278. View

Leslie W . Clinical review: Ethnic differences in bone mass--clinical implications. J Clin Endocrinol Metab. 2012; 97(12):4329-40. DOI: 10.1210/jc.2012-2863. View

10.

Bauer D, Sklarin P, Stone K, Black D, Nevitt M, Ensrud K . Biochemical markers of bone turnover and prediction of hip bone loss in older women: the study of osteoporotic fractures. J Bone Miner Res. 1999; 14(8):1404-10. DOI: 10.1359/jbmr.1999.14.8.1404. View

11.

Behnke B, Altrogge H, Delling G, Kruse H, Muller-Wiefel D . Bone mineral density in pediatric patients after renal transplantation. Clin Nephrol. 1996; 46(1):24-9. View

12.

Florencio-Silva R, Sasso G, Sasso-Cerri E, Simoes M, Cerri P . Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells. Biomed Res Int. 2015; 2015:421746. PMC: 4515490. DOI: 10.1155/2015/421746. View

13.

Delmas P, Eastell R, Garnero P, Seibel M, Stepan J . The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation. Osteoporos Int. 2001; 11 Suppl 6:S2-17. DOI: 10.1007/s001980070002. View

14.

Vaidya R, Shah R . Bone mineral density and reference standards for Indian women. J Midlife Health. 2011; 1(2):55. PMC: 3122503. DOI: 10.4103/0976-7800.76211. View

15.

Cosman F, de Beur S, LeBoff M, Lewiecki E, Tanner B, Randall S . Clinician's Guide to Prevention and Treatment of Osteoporosis. Osteoporos Int. 2014; 25(10):2359-81. PMC: 4176573. DOI: 10.1007/s00198-014-2794-2. View

16.

Meszaros S, Toth E, Ferencz V, Csupor E, Hosszu E, Horvath C . Calcaneous quantitative ultrasound measurements predicts vertebral fractures in idiopathic male osteoporosis. Joint Bone Spine. 2007; 74(1):79-84. DOI: 10.1016/j.jbspin.2006.04.008. View

17.

Vestergaard P, Hermann A, Gram J, Jensen L, Eiken P, Abrahamsen B . Evaluation of methods for prediction of bone mineral density by clinical and biochemical variables in perimenopausal women. Maturitas. 2001; 40(3):211-20. DOI: 10.1016/s0378-5122(01)00240-7. View

18.

Khadilkar A, Mandlik R . Epidemiology and treatment of osteoporosis in women: an Indian perspective. Int J Womens Health. 2015; 7:841-50. PMC: 4621228. DOI: 10.2147/IJWH.S54623. View

19.

Woitge H, Scheidt-Nave C, Kissling C, Leidig-Bruckner G, Meyer K, Grauer A . Seasonal variation of biochemical indexes of bone turnover: results of a population-based study. J Clin Endocrinol Metab. 1998; 83(1):68-75. DOI: 10.1210/jcem.83.1.4522. View

20.

Seifert-Klauss V, Fillenberg S, Schneider H, Luppa P, Mueller D, Kiechle M . Bone loss in premenopausal, perimenopausal and postmenopausal women: results of a prospective observational study over 9 years. Climacteric. 2012; 15(5):433-40. DOI: 10.3109/13697137.2012.658110. View